- Home >
- Clinicals Trials >
- ALCYTA (IC 2020-12)
ALCYTA (IC 2020-12)
Exploration of Adaptive Antitumoral Immune Cells Through Leukapheresis in Cancer Patients: ALCYTA
- Open at Paris since : 09/06/2022
- Open at Saint-Cloud since : 09/06/2022
- Target : Adult
- Phase : Clinical trial
Trial description
The study will evaluate the detection of tumor-antigen specific immune cells in cancer patients in whom the role of the immune system is suspected.
Url of the trialMain investigator
